141 related articles for article (PubMed ID: 34781805)
1. Efficacy of Infliximab in Disease Control of Refractory Orbital Myositis.
El Nokrashy A; Lightman S; Tomkins-Netzer O
Ocul Immunol Inflamm; 2023 Jan; 31(1):153-157. PubMed ID: 34781805
[TBL] [Abstract][Full Text] [Related]
2. Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximab.
Sahlin S; Lignell B; Williams M; Dastmalchi M; Orrego A
Acta Ophthalmol; 2009 Nov; 87(8):906-8. PubMed ID: 18631325
[TBL] [Abstract][Full Text] [Related]
3. Adalimumab for orbital myositis in a patient with Crohn's disease who discontinued infliximab: a case report and review of the literature.
Verma S; Kroeker KI; Fedorak RN
BMC Gastroenterol; 2013 Apr; 13():59. PubMed ID: 23556424
[TBL] [Abstract][Full Text] [Related]
4. Infliximab Reverses Symptoms and May Protect from Developing Chronic Restrictive Ophthalmopathy in Children with Familial Orbital Myositis: A Case Report.
Huynh A; Siggs OM; Wainstein BK; Gray PE
Ocul Immunol Inflamm; 2023 Jul; 31(5):1097-1100. PubMed ID: 35622932
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic orbital myositis.
Yan J; Wu P
J Craniofac Surg; 2014 May; 25(3):884-7. PubMed ID: 24670274
[TBL] [Abstract][Full Text] [Related]
6. Diagnostics and treatment of orbital myositis.
Pidro A; Dizdarević A; Jovanović N; Čerim A; Sačak E; Miokovic AP
Rom J Ophthalmol; 2022; 66(2):173-177. PubMed ID: 35935078
[No Abstract] [Full Text] [Related]
7. Bilateral diffuse orbital myositis in a patient with relapsing ulcerative colitis.
Bennion J; Harris MA; Sivak-Callcott JA; Nguyen J
Ophthalmic Plast Reconstr Surg; 2012; 28(5):e119-20. PubMed ID: 22366668
[TBL] [Abstract][Full Text] [Related]
8. Tocilizumab as an alternative for corticosteroid-refractory orbital myositis.
Meca Casasnovas N; Sangrador Pelluz C; Sotoca J
J Neuroimmunol; 2021 Jul; 356():577573. PubMed ID: 33933820
[No Abstract] [Full Text] [Related]
9. Orbital inflammation following COVID-19 vaccination: A case series and literature review.
Ang T; Tong JY; Patel S; Khong JJ; Selva D
Int Ophthalmol; 2023 Sep; 43(9):3391-3401. PubMed ID: 37198501
[TBL] [Abstract][Full Text] [Related]
10. Orbital myositis: diagnosis and management.
Costa RM; Dumitrascu OM; Gordon LK
Curr Allergy Asthma Rep; 2009 Jul; 9(4):316-23. PubMed ID: 19656480
[TBL] [Abstract][Full Text] [Related]
11. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab.
Garrity JA; Coleman AW; Matteson EL; Eggenberger ER; Waitzman DM
Am J Ophthalmol; 2004 Dec; 138(6):925-30. PubMed ID: 15629282
[TBL] [Abstract][Full Text] [Related]
12. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP
Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227
[TBL] [Abstract][Full Text] [Related]
13. Relapsing migratory idiopathic orbital inflammation: six new cases and review of the literature.
Avni-Zauberman N; Tripathy D; Rosen N; Ben Simon GJ
Br J Ophthalmol; 2012 Feb; 96(2):276-80. PubMed ID: 21527417
[TBL] [Abstract][Full Text] [Related]
14. Orbital myositis associated with discoid lupus erythematosus.
Kono S; Takashima H; Suzuki D; Terada T; Konishi T; Miyajima H
Lupus; 2014 Feb; 23(2):220-2. PubMed ID: 24335011
[No Abstract] [Full Text] [Related]
15. Orbital Myositis: A Comprehensive Review and Reclassification.
McNab AA
Ophthalmic Plast Reconstr Surg; 2020; 36(2):109-117. PubMed ID: 31261163
[TBL] [Abstract][Full Text] [Related]
16. [Rationale for a diagnostic approach in non-Graves' orbital inflammation--Report of 61 patients].
Gavard-Perret A; Lagier J; Delmas J; Delas J; Adenis JP; Robert PY
J Fr Ophtalmol; 2015 Dec; 38(10):912-23. PubMed ID: 26604081
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of idiopathic orbital inflammation with infliximab: an alternative to conventional steroid-sparing agents.
Miquel T; Abad S; Badelon I; Vignal C; Warzocha U; Larroche C; Morax S; Dhote R
Ophthalmic Plast Reconstr Surg; 2008; 24(5):415-7. PubMed ID: 18806671
[TBL] [Abstract][Full Text] [Related]
18. Infliximab "Top-Down" Strategy is Superior to "Step-Up" in Maintaining Long-Term Remission in the Treatment of Pediatric Crohn Disease.
Lee YM; Kang B; Lee Y; Kim MJ; Choe YH
J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):737-43. PubMed ID: 25564801
[TBL] [Abstract][Full Text] [Related]
19. Orbital myositis in a patient with Crohn's disease: A case report of two episodes.
Oliver-Gutierrez D; Garrido-Marin M; Segura-Duch G; Alonso T; Ros-Sanchez E; Oliveres J
J Fr Ophtalmol; 2024 Apr; 47(4):104048. PubMed ID: 38238142
[TBL] [Abstract][Full Text] [Related]
20. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]